I agree that this site is using cookies. You can find further informations here.
X
Hamid, Omid
1129  results:
Search for persons X
?
1

Expert consensus guidelines on management and best practice..:

Betof Warner, Allison ; Hamid, Omid ; Komanduri, Krishna...
Journal for ImmunoTherapy of Cancer.  12 (2024)  2 - p. e008735 , 2024
Link: https://doi.org/10.1136/..
 
?
2

Long-term survival follow-up for tebentafusp in previously ..:

Sacco, Joseph J ; Carvajal, Richard D ; Butler, Marcus O...
Journal for ImmunoTherapy of Cancer.  12 (2024)  6 - p. e009028 , 2024
Link: https://doi.org/10.1136/..
 
?
3

Safety profile of pembrolizumab monotherapy based on an agg..:

Brahmer, Julie R. ; Long, Georgina V. ; Hamid, Omid...
European Journal of Cancer.  199 (2024)  - p. 113530 , 2024
Link: https://doi.org/10.1016/..
 
?
4

POLARIS: A phase 2 trial of encorafenib plus binimetinib ev..:

Menzies, Alexander M ; Long, Georgina V ; Kohn, Amiee...
Neuro-Oncology Advances.  6 (2024)  1 - p. , 2024
Link: https://doi.org/10.1093/..
 
?
5

Randomized Placebo-Controlled, Biomarker-Stratified Phase I..:

Glitza, Isabella C. ; Seo, Yongwoo David ; Spencer, Christine N....
Cancer Discovery.  14 (2024)  7 - p. 1161-1175 , 2024
Link: https://doi.org/10.1158/..
 
?
6

Outcomes of patients with resected stage III/IV acral or mu..:

Jacques, Sarah K. ; McKeown, Janet ; Grover, Piyush...
European Journal of Cancer.  199 (2024)  - p. 113563 , 2024
Link: https://doi.org/10.1016/..
 
?
7

43001 Phase 1 study of fianlimab, a human lymphocyte activa..:

Hamid, Omid ; Weise, Amy ; Lewis, Karl D....
Journal of the American Academy of Dermatology.  89 (2023)  3 - p. AB207 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Tebentafusp in combination with durvalumab and/or tremelimu..:

Hamid, Omid ; Hassel, Jessica C ; Shoushtari, Alexander N...
Journal for ImmunoTherapy of Cancer.  11 (2023)  6 - p. e006747 , 2023
Link: https://doi.org/10.1136/..
 
?
9

The "Great Debate" at Melanoma Bridge 2022, Naples, Decembe..:

Ascierto, Paolo A. ; Blank, Christian ; Eggermont, Alexander M....
Journal of Translational Medicine.  21 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
10

Society for Immunotherapy of Cancer (SITC) consensus defini..:

Kluger, Harriet ; Barrett, J Carl ; Gainor, Justin F...
Journal for ImmunoTherapy of Cancer.  11 (2023)  3 - p. e005921 , 2023
Link: https://doi.org/10.1136/..
 
?
11

Phase 1 study of fianlimab, a human lymphocyte activation g..:

Hamid, Omid ; Lewis, Karl ; Weise, Amy...
SKIN The Journal of Cutaneous Medicine.  7 (2023)  2 - p. s179 , 2023
Link: https://doi.org/10.25251..
 
?
12

Society for Immunotherapy of Cancer (SITC) clinical practic..:

Pavlick, Anna C ; Ariyan, Charlotte E ; Buchbinder, Elizabeth I...
Journal for ImmunoTherapy of Cancer.  11 (2023)  10 - p. e006947 , 2023
Link: https://doi.org/10.1136/..
 
?
13

Perspectives in Immunotherapy: meeting report from Immunoth..:

Ascierto, Paolo A. ; Avallone, Antonio ; Bifulco, Carlo...
Journal of Translational Medicine.  21 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
14

Talimogene laherparepvec in combination with ipilimumab ver..:

Chesney, Jason A ; Puzanov, Igor ; Collichio, Frances A...
Journal for ImmunoTherapy of Cancer.  11 (2023)  5 - p. e006270 , 2023
Link: https://doi.org/10.1136/..
 
?
15

Response to Lifileucel Tumor-Infiltrating Lymphocyte (TIL) ..:

Sarnaik, Amod ; Chesney, Jason ; Medina, Theresa...
Transplantation and Cellular Therapy.  29 (2023)  2 - p. S223-S224 , 2023
Link: https://doi.org/10.1016/..
 
1-15